AUPR257901A0 - Diagnosis and treatment of malignant lymphoma - Google Patents

Diagnosis and treatment of malignant lymphoma

Info

Publication number
AUPR257901A0
AUPR257901A0 AUPR2579A AUPR257901A AUPR257901A0 AU PR257901 A0 AUPR257901 A0 AU PR257901A0 AU PR2579 A AUPR2579 A AU PR2579A AU PR257901 A AUPR257901 A AU PR257901A AU PR257901 A0 AUPR257901 A0 AU PR257901A0
Authority
AU
Australia
Prior art keywords
diagnosis
treatment
malignant lymphoma
lymphoma
malignant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AUPR2579A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Intreat Pty Ltd
Original Assignee
Intreat Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intreat Pty Ltd filed Critical Intreat Pty Ltd
Priority to AUPR2579A priority Critical patent/AUPR257901A0/en
Publication of AUPR257901A0 publication Critical patent/AUPR257901A0/en
Priority to ES08156593T priority patent/ES2383712T3/en
Priority to ES02715313T priority patent/ES2320421T3/en
Priority to DE60230482T priority patent/DE60230482D1/en
Priority to TW091100845A priority patent/TWI319011B/en
Priority to DK08156593.9T priority patent/DK1961767T3/en
Priority to AT02715313T priority patent/ATE418565T1/en
Priority to CA2434490A priority patent/CA2434490C/en
Priority to CNB028050789A priority patent/CN100497385C/en
Priority to CN2009101328012A priority patent/CN101555283B/en
Priority to PT02715313T priority patent/PT1360203E/en
Priority to PCT/AU2002/000061 priority patent/WO2002057306A1/en
Priority to AT08156593T priority patent/ATE548383T1/en
Priority to EP08156593A priority patent/EP1961767B1/en
Priority to MYPI20020182A priority patent/MY158262A/en
Priority to EP02715313A priority patent/EP1360203B1/en
Priority to JP2002558379A priority patent/JP4384852B2/en
Priority to DK02715313T priority patent/DK1360203T3/en
Priority to US10/622,313 priority patent/US7326415B2/en
Priority to AU2003235005A priority patent/AU2003235005B2/en
Priority to HK05103553.8A priority patent/HK1070903A1/en
Priority to US11/968,607 priority patent/US7531171B2/en
Priority to HK09101899.1A priority patent/HK1123311A1/en
Priority to US12/417,989 priority patent/US7888473B2/en
Priority to JP2009112881A priority patent/JP4457169B2/en
Priority to HK10103195.5A priority patent/HK1138013A1/en
Priority to US12/975,341 priority patent/US8080635B2/en
Priority to US13/298,222 priority patent/US8399617B2/en
Priority to US13/766,630 priority patent/US8709425B2/en
Priority to US14/218,935 priority patent/US20140323693A1/en
Priority to US14/726,391 priority patent/US9663584B2/en
Priority to US15/498,301 priority patent/US10450380B2/en
Priority to US16/568,072 priority patent/US20200071419A1/en
Abandoned legal-status Critical Current

Links

AUPR2579A 2001-01-17 2001-01-17 Diagnosis and treatment of malignant lymphoma Abandoned AUPR257901A0 (en)

Priority Applications (33)

Application Number Priority Date Filing Date Title
AUPR2579A AUPR257901A0 (en) 2001-01-17 2001-01-17 Diagnosis and treatment of malignant lymphoma
TW091100845A TWI319011B (en) 2001-01-17 2002-01-17 Diagnosis and treatment of cancers and other conditions
JP2002558379A JP4384852B2 (en) 2001-01-17 2002-01-17 Non-functional P2X7 receptor antibody, diagnosis and treatment of cancer and other conditions
MYPI20020182A MY158262A (en) 2001-01-17 2002-01-17 Diagnosis and treatments of cancers and other conditions
DE60230482T DE60230482D1 (en) 2001-01-17 2002-01-17 ANTIBODIES TO NON-FUNCTIONAL P 2X7 RECEPTORS, DIAGNOSIS AND TREATMENT OF CANCER AND OTHER SUFFERING
DK02715313T DK1360203T3 (en) 2001-01-17 2002-01-17 Antibodies to non-functional P2X7 receptor diagnosis and treatment of cancer disorders and other conditions
DK08156593.9T DK1961767T3 (en) 2001-01-17 2002-01-17 Diagnosis and treatment of cancers and other disorders
AT02715313T ATE418565T1 (en) 2001-01-17 2002-01-17 ANTIBODIES TO NON-FUNCTIONAL P 2 X 7 RECEPTORS, DIAGNOSIS AND TREATMENT OF CANCER AND OTHER CONDITIONS
CA2434490A CA2434490C (en) 2001-01-17 2002-01-17 Antibodies to non-functional p2x7 receptor diagnosis and treatment of cancers and other conditions
ES02715313T ES2320421T3 (en) 2001-01-17 2002-01-17 ANTIBODIES FOR THE DIAGNOSIS OF A NON-FUNCTIONAL P2X7 RECEIVER AND THE TREATMENT OF CANCER AND OTHER AFFECTIONS.
CN2009101328012A CN101555283B (en) 2001-01-17 2002-01-17 Antibodies to non-functional p2x7 receptor, diagnosis and treatment of cancers and other conditions
PT02715313T PT1360203E (en) 2001-01-17 2002-01-17 Antibodies to non-functional p 2 x 7 receptor diagnosis and treatment of cancers and other conditions
PCT/AU2002/000061 WO2002057306A1 (en) 2001-01-17 2002-01-17 Antibodies to non-functional p2x7 receptor diagnosis and treatment of cancers and other conditions
AT08156593T ATE548383T1 (en) 2001-01-17 2002-01-17 DIAGNOSIS AND TREATMENT OF CARCINOMA AND OTHER CONDITIONS
EP08156593A EP1961767B1 (en) 2001-01-17 2002-01-17 Diagnosis and treatment of cancers and other conditions
CNB028050789A CN100497385C (en) 2001-01-17 2002-01-17 Antibodies of non-functional P 2 Chi 7 receptor and its uses of diagnosis and treatment of cancers and other syndrome
EP02715313A EP1360203B1 (en) 2001-01-17 2002-01-17 Antibodies to non-functional p 2 x 7 receptor diagnosis and treatment of cancers and other conditions
ES08156593T ES2383712T3 (en) 2001-01-17 2002-01-17 Diagnosis and treatment of cancers and other conditions
US10/622,313 US7326415B2 (en) 2001-01-17 2003-07-17 Antibodies to non-functional P2X7 receptor
AU2003235005A AU2003235005B2 (en) 2001-01-17 2003-08-14 Antibodies to non-functional P2X7 receptor diagnosis and treatment of cancers and other conditions
HK05103553.8A HK1070903A1 (en) 2001-01-17 2005-04-26 Antibodies to non-functional p2x7 receptor diagnosis and treatment of cancers and other conditions
US11/968,607 US7531171B2 (en) 2001-01-17 2008-01-02 Antibodies to non-functional P2X7 receptor
HK09101899.1A HK1123311A1 (en) 2001-01-17 2009-02-27 Diagnosis and treatment of cancers and other conditions
US12/417,989 US7888473B2 (en) 2001-01-17 2009-04-03 Non-functional P2X7 receptor
JP2009112881A JP4457169B2 (en) 2001-01-17 2009-05-07 Diagnosis and treatment of non-functional P2X7 receptor antibodies, cancer and other conditions
HK10103195.5A HK1138013A1 (en) 2001-01-17 2010-03-29 Antibodies to non-functional p2x7 receptor diagnosis and treatment of cancers and other conditions
US12/975,341 US8080635B2 (en) 2001-01-17 2010-12-21 Non-functional P2X7 receptor
US13/298,222 US8399617B2 (en) 2001-01-17 2011-11-16 Non-functional P2X7 receptor
US13/766,630 US8709425B2 (en) 2001-01-17 2013-02-13 Antibodies to non-functional P2X7 receptor
US14/218,935 US20140323693A1 (en) 2001-01-17 2014-03-18 Antibodies To Non-Functional P2X7 Receptor
US14/726,391 US9663584B2 (en) 2001-01-17 2015-05-29 Antibodies to non-functional P2X7 receptor
US15/498,301 US10450380B2 (en) 2001-01-17 2017-04-26 Polypeptide immunogen for generating an antibody to non-functional P2X7 receptor
US16/568,072 US20200071419A1 (en) 2001-01-17 2019-09-11 Antibodies to non-functional p2x7 receptor

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPR2579A AUPR257901A0 (en) 2001-01-17 2001-01-17 Diagnosis and treatment of malignant lymphoma

Publications (1)

Publication Number Publication Date
AUPR257901A0 true AUPR257901A0 (en) 2001-02-08

Family

ID=3826614

Family Applications (1)

Application Number Title Priority Date Filing Date
AUPR2579A Abandoned AUPR257901A0 (en) 2001-01-17 2001-01-17 Diagnosis and treatment of malignant lymphoma

Country Status (1)

Country Link
AU (1) AUPR257901A0 (en)

Similar Documents

Publication Publication Date Title
AU2002225219A1 (en) Diagnosis and treatment of multiple sclerosis
GB9903841D0 (en) Diagnosis and treatment of cancer
AU2003900747A0 (en) Diagnosis and treatment of pancreatic cancer
AU2197100A (en) Treatment of tooth surfaces and substance therefor
AU2002251844A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU2002247004A1 (en) Methods of diagnosis and treatment of osteoporosis
AU2002319338A1 (en) Cancer specific oligosaccharide sequences and use thereof
AU2002303219A1 (en) Compositions and methods for the therapy and diagnosis of cancer
MXPA03008582A (en) Agents and methods for treatment of cancer.
AU2002258728A1 (en) Gene brcc-3 and diagnostic and therapeutic uses thereof
AU2003268295A1 (en) "diagnosis and treatment of infertility"
AU2002305151A1 (en) Gene scc-112 and diagnostic and therapeutic uses thereof
AU2002303261A1 (en) Gene brcc2 and diagnostic and therapeutic uses thereof
GB9811598D0 (en) Diagnosis and treatment of cancer
AU2001243349A1 (en) Methods for the diagnosis and treatment of breast cancer
AU2002319286A1 (en) Skin treatment
AU2002330724A1 (en) Diagnosis, prevention and treatment of cancer
AU2002327639A1 (en) Detection and treatment of cancers of breast
AU2001245414A1 (en) Treatment of allergies
EP1409734A4 (en) Diagnosis and treatment of cancer
AU2002306600A1 (en) Sperm protein 17 for the diagnosis and treatment of cancer
AU2002366195A1 (en) Use of bisindolmaleimide and gemcitabine for the treatment of cancer
AU2002346049A1 (en) Coactivators in the diagnosis and treatment of breast cancer
AUPQ367699A0 (en) Treatment of cancer
AU5552400A (en) Treatment of cancer